Compare ANIX & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIX | ATLX |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 91.2M |
| IPO Year | 2013 | 2012 |
| Metric | ANIX | ATLX |
|---|---|---|
| Price | $2.68 | $2.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.75 | N/A |
| AVG Volume (30 Days) | ★ 306.6K | 260.1K |
| Earning Date | 09-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.82 | ★ 47.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $210,000.00 | $92,491.00 |
| Revenue This Year | N/A | $8.12 |
| Revenue Next Year | N/A | $217,536.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.32 | $2.07 |
| 52 Week High | $5.46 | $8.25 |
| Indicator | ANIX | ATLX |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 26.78 |
| Support Level | $2.62 | N/A |
| Resistance Level | $3.09 | $2.70 |
| Average True Range (ATR) | 0.14 | 0.15 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 7.17 | 9.76 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.